Found 70 matching trials
Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer
PHASE1This clinical trial will be conducted as a single-center, open-label, Phase...
Location
University of Iowa Hospitals and Clinics
Nivolumab and Yttrium Y 90 Glass Microspheres in Treating Patients With Advanced Liver Cancer
PHASE1The purpose of this study is to identify maximum tolerated dose (MTD), that...
Location
Northwestern University
Yttrium-90 Radiation Segmentectomy for Hepatocellular Carcinoma
NAThis is a prospective, single-blinded, single-arm, open-label Phase II tria...
Location
University of California, San Francisco
Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein
PHASE3This is a two-arm, open-label, prospective, multi-center, randomized, activ...
Location
Northwestern Medical Faculty Foundation, Div of Hematology/Oncology
Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial
PHASE1This phase I/II trial tests the safety, side effects and effectiveness of r...
Location
UCLA / Jonsson Comprehensive Cancer Center
TheraSphere With Durvalumab and Tremelimumab for HCC
PHASE2The objective of the ROWAN clinical study is to assess the efficacy of loca...
Status
Active Not Recruiting
Location
University of California San Diego
Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia
NAEvaluate the safety and efficacy of Yttrium-90 (90Y) radioembolization for ...
Location
Northwestern University/Northwestern Memorial Hospital
Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors
PHASE1The purpose of this study is to provide supervised access to treatment with...
Location
Cancer Treatment Centers of America at Southwestern Regional Medical Center
Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma
PHASE2The purpose of this study is to assess efficacy and tolerance of intra-hepa...
Location
Hôpital Beaujon - Service de Chirurgie
Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Disease
PHASE1The goal of this clinical research study is to find the highest tolerable d...
Location
Multiple Locations